JurisdictionsTopicsUpdatesWorkflowsCompareChat with ExpertMarketplacePricing
🇳🇴👤

Patient Access (Named-Patient)

Named-patient access pathway for medicinal cannabis in Norway

General Verified 2026-04-20

Workflow steps

  1. Patient Need
    Patient has condition potentially treatable with cannabis medicine. Must have exhausted conventional treatment options first.
  2. Referral to Specialist
    GP refers to specialist physician (neurologist, oncologist, or pain specialist). Specialist evaluation required before cannabis prescription considered.
    • GP referral to specialist
    • Documented conventional treatment failure
    • Condition assessment by specialist
  3. Specialist Section 4-4 Application
    Specialist applies to NoMA for Section 4-4 authorization to prescribe an unlicensed cannabis medicine. Clinical justification must be strong.
    • Section 4-4 application to NoMA
    • Detailed clinical history
    • Proposed product and dosing rationale
    • Monitoring plan
  4. NoMA approval?
    NoMA reviews application. Conservative — approval not guaranteed. Processing typically 4–6 weeks.
  5. Patient Access Granted ✓
    Medication dispensed via hospital pharmacy. Ongoing monitoring by prescribing specialist required.
GMP Pathway